Blab Entertainment
A24s Adam Wingard Thriller Onslaught Set for September 4 Release
Adam Wingard’s upcoming action thriller, Onslaught, is slated for a U.S. theatrical release on September 4, 2026. The film, produced and distributed by A24, follows a former U.S. Army sniper who must protect her young daughter from a group of genetically engineered super‑soldiers that escape a secret military facility and overrun a desert town. A24 released an official trailer on June 2, 2026, which showcases the movie’s blend of high‑intensity combat, supernatural elements, and moments of dark humor. The September release places Onslaught in a month that also features major studio titles, but the film’s niche appeal could attract genre‑focused audiences.
Wingard first attracted attention with the 2011 horror film You’re Next, and he has since directed a mix of genre titles that combine horror and action. His filmography includes The Guest (2014), Blair Witch (2016), Death Note (2017), and the Godzilla‑Kong crossover movies of 2021 and 2024. Wingard’s work is noted for kinetic pacing and a willingness to blend visceral violence with stylized storytelling. Onslaught is written by Simon Barrett, a frequent collaborator who has co‑written several of Wingard’s earlier projects. The director’s experience with high‑concept genre films informs the movie’s design and tone.
The cast centers on Adria Arjona, who plays the mother‑sniper, and includes Dan Stevens, Eric Wareheim, Reginald VelJohnson, Michael Biehn, MMA star Alex Pereira, Drew Starkey, and Rebecca Hall. Hall’s character is a former soldier dealing with post‑traumatic stress, a detail that adds emotional depth to the otherwise action‑heavy narrative. Pereira, known for his combat background, portrays one of the super‑soldiers, bringing a physical presence to the battlefield scenes. Starkey’s role is described as a secondary antagonist with a tongue‑in‑cheek makeup routine, hinting at the film’s self‑aware humor.
The trailer, released on June 2, 2026, shows the desert town being overrun by the super‑soldiers and the protagonist’s home turning into a battleground. Scenes depict Arjona training with an AR‑style weapon, her daughter nearby, and flashbacks that suggest the soldier’s wartime past. The film’s tone is self‑parodic; the trailer hints at comedic moments, such as Starkey’s exaggerated makeup, while maintaining intense action sequences. The supernatural element is implied through brief visual cues, but the primary focus remains on the conflict between the mother‑sniper and the genetically engineered forces.
A24, founded in 2012 by Daniel Katz, David Fenkel, and John Hodges, began as a film distributor and quickly built a reputation for arthouse and horror titles such as Room (2015) and The Witch (2015). The studio’s 2022 film Everything Everywhere All at Once won the Academy Award for Best Picture and marked a shift toward higher‑budget, mainstream projects. In recent years, A24 has expanded into television and has produced a range of genre films that blend artistic ambition with commercial appeal. By producing and distributing Onslaught, the company continues its strategy of investing in high‑concept action movies that can attract both critics and box‑office audiences.
The film’s release strategy will likely follow A24’s recent model of a limited theatrical run followed by a digital release. While specific box‑office projections are not yet available, the studio’s track record suggests that Onslaught could perform well in the domestic market, especially among fans of action‑thrillers and genre mash‑ups. The presence of MMA star Alex Pereira may broaden the film’s appeal to sports fans and younger viewers. Additionally, the self‑parodic tone could attract audiences who appreciate genre satire, positioning the movie as a distinctive entry in the September slate.
In summary, Onslaught is an action‑thriller that blends kinetic violence, supernatural hints, and self‑aware humor. Directed by Adam Wingard and written by Simon Barrett, the film follows a former sniper protecting her daughter from genetically engineered super‑soldiers. With a cast that includes Adria Arjona, Alex Pereira, and Rebecca Hall, the movie is set for a September 4, 2026 release by A24. As the release date approaches, industry observers will monitor how the film performs against other September releases and whether A24’s continued investment in genre‑focused action titles yields commercial success.
Wingard first attracted attention with the 2011 horror film You’re Next, and he has since directed a mix of genre titles that combine horror and action. His filmography includes The Guest (2014), Blair Witch (2016), Death Note (2017), and the Godzilla‑Kong crossover movies of 2021 and 2024. Wingard’s work is noted for kinetic pacing and a willingness to blend visceral violence with stylized storytelling. Onslaught is written by Simon Barrett, a frequent collaborator who has co‑written several of Wingard’s earlier projects. The director’s experience with high‑concept genre films informs the movie’s design and tone.
The cast centers on Adria Arjona, who plays the mother‑sniper, and includes Dan Stevens, Eric Wareheim, Reginald VelJohnson, Michael Biehn, MMA star Alex Pereira, Drew Starkey, and Rebecca Hall. Hall’s character is a former soldier dealing with post‑traumatic stress, a detail that adds emotional depth to the otherwise action‑heavy narrative. Pereira, known for his combat background, portrays one of the super‑soldiers, bringing a physical presence to the battlefield scenes. Starkey’s role is described as a secondary antagonist with a tongue‑in‑cheek makeup routine, hinting at the film’s self‑aware humor.
The trailer, released on June 2, 2026, shows the desert town being overrun by the super‑soldiers and the protagonist’s home turning into a battleground. Scenes depict Arjona training with an AR‑style weapon, her daughter nearby, and flashbacks that suggest the soldier’s wartime past. The film’s tone is self‑parodic; the trailer hints at comedic moments, such as Starkey’s exaggerated makeup, while maintaining intense action sequences. The supernatural element is implied through brief visual cues, but the primary focus remains on the conflict between the mother‑sniper and the genetically engineered forces.
A24, founded in 2012 by Daniel Katz, David Fenkel, and John Hodges, began as a film distributor and quickly built a reputation for arthouse and horror titles such as Room (2015) and The Witch (2015). The studio’s 2022 film Everything Everywhere All at Once won the Academy Award for Best Picture and marked a shift toward higher‑budget, mainstream projects. In recent years, A24 has expanded into television and has produced a range of genre films that blend artistic ambition with commercial appeal. By producing and distributing Onslaught, the company continues its strategy of investing in high‑concept action movies that can attract both critics and box‑office audiences.
The film’s release strategy will likely follow A24’s recent model of a limited theatrical run followed by a digital release. While specific box‑office projections are not yet available, the studio’s track record suggests that Onslaught could perform well in the domestic market, especially among fans of action‑thrillers and genre mash‑ups. The presence of MMA star Alex Pereira may broaden the film’s appeal to sports fans and younger viewers. Additionally, the self‑parodic tone could attract audiences who appreciate genre satire, positioning the movie as a distinctive entry in the September slate.
In summary, Onslaught is an action‑thriller that blends kinetic violence, supernatural hints, and self‑aware humor. Directed by Adam Wingard and written by Simon Barrett, the film follows a former sniper protecting her daughter from genetically engineered super‑soldiers. With a cast that includes Adria Arjona, Alex Pereira, and Rebecca Hall, the movie is set for a September 4, 2026 release by A24. As the release date approaches, industry observers will monitor how the film performs against other September releases and whether A24’s continued investment in genre‑focused action titles yields commercial success.
